Arcus Biosciences, Inc.
Inhibitors of adenosine 5'-nucleotidase
Last updated:
Abstract:
Compounds that modulate the conversion of AMP to adenosine by 5'-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5'-nucleotidase, ecto is also provided.
Status:
Grant
Type:
Utility
Filling date:
2 Oct 2017
Issue date:
13 Jul 2021